These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37626789)

  • 21. High Levels of Acquired HIV Drug Resistance Following Virological Nonsuppression in HIV-Infected Women from a High-Risk Cohort in Uganda.
    Segujja F; Omooja J; Lunkuse S; Nanyonjo M; Nabirye SE; Nassolo F; Bugembe DL; Bbosa N; Kateete DP; Ssenyonga W; Mayanja Y; Nsubuga RN; Seeley J; Kaleebu P; Ssemwanga D
    AIDS Res Hum Retroviruses; 2020 Sep; 36(9):782-791. PubMed ID: 32475121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of HIV-1 drug resistance in treatment-naïve patients and its clinical implications in an antiretroviral treatment program in Cameroon.
    Zoufaly A; Jochum J; Hammerl R; Nassimi N; Raymond Y; Burchard GD; Schmiedel S; Drexler JF; Kay CN; Taka N; Awasom C; Metzner K; Jan vL; Feldt T
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19615. PubMed ID: 25394119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretreatment HIV Drug Resistance and Virologic Outcomes to First-Line Antiretroviral Therapy in Peru.
    Soria J; Mugruza R; Levine M; León SR; Arévalo J; Ticona E; Beck IA; Frenkel LM
    AIDS Res Hum Retroviruses; 2019 Feb; 35(2):150-154. PubMed ID: 30560685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali.
    Germanaud D; Derache A; Traore M; Madec Y; Toure S; Dicko F; Coulibaly H; Traore M; Sylla M; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2010 Jan; 65(1):118-24. PubMed ID: 19933171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases].
    Yalçınkaya T; Köse S
    Mikrobiyol Bul; 2014 Oct; 48(4):585-95. PubMed ID: 25492654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug resistance mutations and its associated factors among 579 HIV/AIDS patients experiencing failure of antiretroviral therapy in Jiangsu Province, China].
    Xiao PP; Lu J; Hu HY; Xu XQ; Ding P; Fu GF; Huan XP; Zhou Y; Yang HT
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Nov; 51(11):988-993. PubMed ID: 29136743
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.
    Ngo-Giang-Huong N; Wittkop L; Judd A; Reiss P; Goetghebuer T; Duiculescu D; Noguera-Julian A; Marczynska M; Giacquinto C; Ene L; Ramos JT; Cellerai C; Klimkait T; Brichard B; Valerius N; Sabin C; Teira R; Obel N; Stephan C; de Wit S; Thorne C; Gibb D; Schwimmer C; Campbell MA; Pillay D; Lallemant M;
    BMC Infect Dis; 2016 Nov; 16(1):654. PubMed ID: 27825316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya.
    Chung MH; Beck IA; Dross S; Tapia K; Kiarie JN; Richardson BA; Overbaugh J; Sakr SR; John-Stewart GC; Frenkel LM
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):246-53. PubMed ID: 25140907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa.
    Kityo C; Thompson J; Nankya I; Hoppe A; Ndashimye E; Warambwa C; Mambule I; van Oosterhout JJ; Wools-Kaloustian K; Bertagnolio S; Easterbrook PJ; Mugyenyi P; Walker AS; Paton NI;
    J Acquir Immune Defic Syndr; 2017 Jun; 75(2):e45-e54. PubMed ID: 28129253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
    Jittamala P; Puthanakit T; Chaiinseeard S; Sirisanthana V
    Pediatr Infect Dis J; 2009 Sep; 28(9):826-30. PubMed ID: 19654564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.
    Kaleebu P; Kirungi W; Watera C; Asio J; Lyagoba F; Lutalo T; Kapaata AA; Nanyonga F; Parry CM; Magambo B; Nazziwa J; Nannyonjo M; Hughes P; Hladik W; Ruberantwari A; Namuwenge N; Musinguzi J; Downing R; Katongole-Mbidde E;
    PLoS One; 2015; 10(12):e0145536. PubMed ID: 26700639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of anti-HIV treatment and drug-resistance mutations in some parts of China].
    Han XX; Zhang M; Cui WG; Liu BG; Wang Yn; Zhang ZN; Liu J; Geng WQ; Diao YY; Dai D; Jiang YJ; Shang H
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):760-4. PubMed ID: 15949383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of HIV-1 drug resistance after virological failure of first-line antiretroviral therapy in Lusaka, Zambia.
    Hudson FP; Mulenga L; Westfall AO; Warrier R; Mweemba A; Saag MS; Stringer JS; Eron JJ; Chi BH
    Antivir Ther; 2019; 24(4):291-300. PubMed ID: 30977467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HAART induced inflammation, toxicity and its determinants among HIV positive children in Addis Ababa, Ethiopia.
    Getaneh Y; Lejissa T; Getahun T; Khairunisa SQ; Husada D; Kuntaman K; Lusida MI
    Heliyon; 2023 May; 9(5):e15779. PubMed ID: 37215860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time to initial highly active antiretroviral therapy discontinuation and its predictors among HIV patients in Felege Hiwot comprehensive specialized hospital: a retrospective cohort study.
    Amera TG; Bogale KA; Tefera YM
    AIDS Res Ther; 2021 Dec; 18(1):93. PubMed ID: 34863200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Proviral DNA to Investigate Virus Resistance Mutations in HIV-infected Zimbabweans.
    Musingwini TV; Zhou DT; Mhandire D; Duri K; Gomo E; Oktedalen O; Chimukangara B; Shamu T; Shawarira-Bote S; Dandara C; Stray-Pedersen B
    Open Microbiol J; 2017; 11():45-52. PubMed ID: 28553415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children.
    Bunupuradah T; Puthanakit T; Kosalaraksa P; Kerr S; Boonrak P; Prasitsuebsai W; Lumbiganon P; Mengthaisong T; Phasomsap C; Pancharoen C; Ruxrungtham K; Ananworanich J
    AIDS Res Ther; 2011 Oct; 8():40. PubMed ID: 22026962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.